Skip to content

Clinical trials

Phase 2 Head and Neck Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 2 Country / region: Taiwan Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20142
20156
20172
20181
20192
20224
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated6
Unknown status4
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
National Taiwan University Hospital2
Pfizer2
Ascendis Pharma A/S1
BeiGene1
Celgene1
Chang Gung Memorial Hospital1
China Medical University Hospital1
Daiichi Sankyo1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms25
Squamous Cell Carcinoma of Head and Neck9
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Pancreatic Neoplasms3
Recurrence3
Carcinoma, Renal Cell2
Ovarian Neoplasms2
Brain Neoplasms1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.